Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
9
currently held
Exits tracked
8
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capital
Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks agoCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminLauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month agoBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin14 companies matching
Galderma
Ardian Co-Investment Fund V
SwitzerlandSector
Pharma
InvestorArdian
Entry
2019
Hold
7yr
Owners
3
Dec Group
capiton VI
SwitzerlandSector
Pharma
Investorcapiton
Entry
2020
Hold
5yr
Owners
2
EffRx Pharmaceuticals
Sobera Capital Fund IV
SwitzerlandSector
Pharma
InvestorSobera Capital
Entry
2018
Hold
5yr
Exit
2023
to Abiogen Pharma
Acino
Ardian Co-Investment Fund III
SwitzerlandSector
Pharma
InvestorArdian
Entry
2013
Hold
9yr
Owners
2
Exit
2022
to ADQ
Actelion Holding Ltd
HealthCap (early funds)
SwitzerlandSector
Pharma
InvestorHealthCap
Entry
1997
Hold
20yr
Exit
2017
to Johnson & Johnson
Nycomed
Nordic Capital (early funds)
SwitzerlandSector
Pharma
InvestorNordic Capital
Entry
2002
Hold
9yr
Exit
2011
to Takeda
Nycomed Pharma
Nordic Capital (early funds)
SwitzerlandSector
Pharma
InvestorNordic Capital
Entry
2002
Hold
9yr
Exit
2011
to Takeda
Develco Pharma
SHS V
SwitzerlandSector
Pharma
InvestorSHS Gesellschaft für Beteiligungsmanagement
Entry
2020
Hold
6yr
Sintetica
Ardian Buyout Fund VII
SwitzerlandSector
Pharma
InvestorArdian
Entry
2019
Hold
7yr
ten23 health
3i Group plc (Evergreen balance sheet)
SwitzerlandSector
Pharma
Investor3i
Entry
2021
Hold
5yr
Aphaia Pharma
Bioventure Club Deals
SwitzerlandSector
Pharma
InvestorBioventure Management
Entry
2018
Hold
8yr
InfoRLife
BC Partners XII
SwitzerlandSector
Pharma
InvestorBC Partners
Entry
2026
Hold
0yr
NUCLIDIUM AG
Seedfonds Bayern
SwitzerlandSector
Pharma
InvestorBayern Kapital
Entry
2025
Hold
1yr
Pentapharm
Orlando Capital V
SwitzerlandSector
Pharma
InvestorOrlando Management
Entry
2025
Hold
1yr